The Role of PET-CT in Mediastinal Lymph Node Staging in Non-small Cell Lung Cancer

被引:0
|
作者
Bellek, Ebru [1 ]
Erturan, Salih Serdar [1 ]
Hallac, Metin [3 ]
Sonmezoglu, Kerim [3 ]
Kaynak, Kamil [2 ]
Bozkurt, Kursat [2 ]
Akman, Canan [4 ]
Oz, Buge [5 ]
Yaman, Mustafa [1 ]
机构
[1] Istanbul Univ, Cerrahpasa Tip Fak, Gogus Hastaliklari AD, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Tip Fak, Gogus Cerrahisi AD, Istanbul, Turkey
[3] Istanbul Univ, Cerrahpasa Tip Fak, Nukleer Tip AD, Istanbul, Turkey
[4] Istanbul Univ, Cerrahpasa Tip Fak, Radyol AD, Istanbul, Turkey
[5] Istanbul Univ, Cerrahpasa Tip Fak, Patol AD, Istanbul, Turkey
关键词
positron emission tomography (PET); standart uptake value (SUV);
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Aim: The aim of this study was to determine the overall accuracy, sensitivity and specificity of both CT and PET-CT in identifying and classifying the presence of metastatic intra-thoracic lymph nodes and their potential role in the treatment of lung cancer. Material and methods: Forty four (mean age 60.7, male/female ratio: 37/7) patients with potentially resectable non-small cell lung cancer have been enrolled. All patients underwent flexibl bronchoscopy, CT scanning and PET-CT imaging prior to mediastinoscopy. Mediastinostomy was performed in two patients. Thirty three patients with negative mediastinoscopy and three patients after neoadjuvant chemotherapy, total of 37 patients went through thoracotomy. Results: The overall sensitivity, specificity and accuracy of CT scan in preoperative staging were found 66.7%, 62.1%, 63.6%, respectively. The negative and positive predictive values of CT scan were 78.3% and 47.6%. CT imaging correctly identified 29 patients (65.9%). Seven patients (15.9%) were under-staged while eight patients (18.1%) were over-staged. Based on PETCT findings, overall sensitivity, specificity and accuracy for staging mediastinal lymph nodes were 86.7%, 65.5% and 72.7%, respectively. The negative and positive predictive values of PET-CT were as follows; 90.5% and 56.5%. Overall, interpretations based on PET-CT staged 65.9% (29 patients) correctly, down-staged six patients (13.6%) and over-staged nine patients. The false-negative rate was 13.3% while the false-positive rate was 34.5%. Conclusion: CT scan and PET-CT perform similarly in the mediastinal staging of non-small cell lung cancer (p= 0.05, Mc Nemar test), both tests are conditionally dependent and provide complementary information, and their diagnostic value mainly resides on the negative results. Although, statistically insignificant, PET-CT has a superior sensitivity and better negative predictive value over CT scan. Based on the relationship between SUV-max value and characteristics of tumor, a significant increase in SUV-max value appeared to be correlated with the tumor size and squamous cell carcinoma sub-type.
引用
下载
收藏
页码:13 / 20
页数:8
相关论文
共 50 条
  • [1] Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT
    Rosa, Raquel
    Maia, Dionisio
    Alves, Ana
    Lopes, Telma
    Goncalves, Ines
    Reis, Joao
    Bravio, Ivan
    Baptista, Pedro
    Martelo, Fernando
    Cardoso, Joao
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [2] Accuracy of integrated PET-CT for mediastinal lymph node metastases in non-small cell lung cancer
    Moreno Garcia, V.
    De Castro, J.
    Feliu, J.
    Belda, C.
    Barriuso, J.
    Marin, M. D.
    Gonzalez Baron, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 169 - 169
  • [3] PET-CT compared to invasive mediastinal staging in non-small cell lung cancer (NSCLC)
    Darling, G.
    Maziak, D.
    Inculet, R.
    Gulenchyn, K.
    Driedger, A.
    Ung, Y.
    Miller, J.
    Gu, C.
    Evans, W.
    Levine, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Preoperatory mediastinal lymph node staging of non small cell lung cancer with 18-F-FDG PET-CT
    Marin, M.
    Coronado, M.
    Couto, R.
    Rodado, S.
    Frutos, L.
    Escabias, C.
    Coya, J.
    Martin Curto, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S287 - S287
  • [5] PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer
    Schmidt-Hansen, Mia
    Baldwin, David R.
    Hasler, Elise
    Zamora, Javier
    Abraira, Victor
    Roque i Figuls, Marta
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (11):
  • [6] PET-CT for evaluation of mediastinal lymph node staging of non-small-cell lung cancer in a Tuberculosis-endemic area
    Shaw, J. A.
    Irusen, E. M.
    Von Groote-Bidlingmaier, F.
    Warwick, J. M.
    Jeremic, B.
    Koegelenberg, C. F. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S481 - S481
  • [7] Mediastinal staging lymph node probability map in non-small cell lung cancer
    J. Bordas-Martinez
    J.L. Vercher-Conejero
    G. Rodriguez-González
    P.C. Notta
    C. Martin Cabeza
    N. Cubero
    R.M. Lopez-Lisbona
    M. Diez-Ferrer
    C. Tebé
    S. Santos
    M. Cortes-Romera
    A. Rosell
    Respiratory Research, 26 (1)
  • [8] Can the negative predictive value of CT-PET for mediastinal lymph node staging in non-small cell lung cancer be trusted?
    Picozzi, N. M.
    Pillai, P.
    Phillips, R.
    Gupta, U.
    Coulden, R.
    Beadsmoore, C.
    Screaton, N.
    Rassl, D.
    Rintoul, R. C.
    LUNG CANCER, 2008, 60 : S6 - S6
  • [9] Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT
    Gao, Sarah J.
    Kim, Anthony W.
    Puchalski, Jonathan T.
    Bramley, Kyle
    Detterbeck, Frank C.
    Boffa, Daniel J.
    Decker, Roy H.
    LUNG CANCER, 2017, 109 : 36 - 41
  • [10] Role of Mediastinal Lymph Node Dissection in Non-Small Cell Lung Cancer
    Boeluekbas, Servet
    Eberlein, Michael H.
    Schirren, Joachim
    CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 78 - 86